Skip to content

Grand Pharmaceutical Group Ltd Sustainability Reports

Grand Pharmaceutical Group Limited is an investment holding company primarily engaged in the development, manufacture, and sale of pharmaceutical preparations, medical devices, bio-technology products, and specialized raw materials. Its key clinical specialties include nuclear medicine anti-tumor therapies, cerebro-cardiovascular precision intervention, and respiratory and ophthalmic treatments.

Sector: Manufacturing

Country: Hong Kong

Exchange: Hong Kong Stock Exchange

LEI: 8945001XW4FS15S8Z778

FIGI: BBG001S7WFP5

11 reports from 2019 to 2025